Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis.

Malda A, Boonstra N, Barf H, de Jong S, Aleman A, Addington J, Pruessner M, Nieman D, de Haan L, Morrison A, Riecher-Rössler A, Studerus E, Ruhrmann S, Schultze-Lutter F, An SK, Koike S, Kasai K, Nelson B, McGorry P, Wood S, Lin A, Yung AY, Kotlicka-Antczak M, Armando M, Vicari S, Katsura M, Matsumoto K, Durston S, Ziermans T, Wunderink L, Ising H, van der Gaag M, Fusar-Poli P, Pijnenborg GHM.

Front Psychiatry. 2019 May 21;10:345. doi: 10.3389/fpsyt.2019.00345. eCollection 2019.

2.

Course and predictors of symptomatic remission in late-life schizophrenia: A 5-year follow-up study in a Dutch psychiatric catchment area.

Lange SMM, Meesters PD, Stek ML, Wunderink L, Penninx BWJH, Rhebergen D.

Schizophr Res. 2019 Jul;209:179-184. doi: 10.1016/j.schres.2019.04.025. Epub 2019 May 9.

PMID:
31080156
3.

[Common mental disorders, the psychiatrist and mental health care services].

Wunderink L.

Tijdschr Psychiatr. 2019;61(4):228-230. Dutch.

4.

Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders.

Wunderink L.

Ther Adv Psychopharmacol. 2019 Apr 8;9:2045125319836566. doi: 10.1177/2045125319836566. eCollection 2019. Review.

5.

Measuring empathy in schizophrenia: The Empathic Accuracy Task and its correlation with other empathy measures.

van Donkersgoed RJM, de Jong S, Aan Het Rot M, Wunderink L, Lysaker PH, Hasson-Ohayon I, Aleman A, Pijnenborg GHM.

Schizophr Res. 2019 Jun;208:153-159. doi: 10.1016/j.schres.2019.03.024. Epub 2019 Apr 19.

PMID:
31006615
6.

Searching for the optimal number of response alternatives for the distress scale of the four-dimensional symptom questionnaire.

van Bebber J, Wigman JTW, Meijer RR, Terluin B, Sytema S, Wunderink L.

BMC Psychiatry. 2019 Mar 29;19(1):103. doi: 10.1186/s12888-019-2070-2.

7.

Functional recovery of individuals with serious mental illnesses: Development and testing of a new short instrument for routine outcome monitoring.

Swildens WE, Visser E, Bähler M, Bruggeman R, Delespaul P, van der Gaag M, de Haan L, Keet R, Nijssen Y, van Os J, Pijnenborg GM, Slooff C, de Vos A, van Weeghel J, Wunderink L, Mulder CL, Wiersma D.

Psychiatr Rehabil J. 2018 Dec;41(4):341-350. doi: 10.1037/prj0000320.

PMID:
30507243
8.

Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.

Weller A, Gleeson J, Alvarez-Jimenez M, McGorry P, Nelson B, Allott K, Bendall S, Bartholomeusz C, Koval P, Harrigan S, O'Donoghue B, Fornito A, Pantelis C, Paul Amminger G, Ratheesh A, Polari A, Wood SJ, van der El K, Ellinghaus C, Gates J, O'Connell J, Mueller M, Wunderink L, Killackey E.

Early Interv Psychiatry. 2018 Nov 29. doi: 10.1111/eip.12769. [Epub ahead of print]

PMID:
30488637
9.

Application of the Patient-Reported Outcomes Measurement Information System (PROMIS) item parameters for Anxiety and Depression in the Netherlands.

van Bebber J, Flens G, Wigman JTW, de Beurs E, Sytema S, Wunderink L, Meijer RR.

Int J Methods Psychiatr Res. 2018 Dec;27(4):e1744. doi: 10.1002/mpr.1744. Epub 2018 Sep 24. No abstract available.

PMID:
30246495
10.

Self-monitoring and personalized feedback based on the experiencing sampling method as a tool to boost depression treatment: a protocol of a pragmatic randomized controlled trial (ZELF-i).

Bastiaansen JA, Meurs M, Stelwagen R, Wunderink L, Schoevers RA, Wichers M, Oldehinkel AJ.

BMC Psychiatry. 2018 Sep 3;18(1):276. doi: 10.1186/s12888-018-1847-z.

11.

A Smart Screening Device for Patients with Mental Health Problems in Primary Health Care: Development and Pilot Study.

van Bebber J, Meijer RR, Wigman JT, Sytema S, Wunderink L.

JMIR Ment Health. 2018 May 28;5(2):e41. doi: 10.2196/mental.9488.

12.

Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia.

de Jong S, van Donkersgoed RJM, Timmerman ME, Aan Het Rot M, Wunderink L, Arends J, van Der Gaag M, Aleman A, Lysaker PH, Pijnenborg GHM.

Psychol Med. 2019 Jan;49(2):303-313. doi: 10.1017/S0033291718000855. Epub 2018 Apr 25.

PMID:
29692285
13.

Towards a comprehensive routine outcome monitoring program for people with psychotic disorders: The Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS).

Bartels-Velthuis AA, Visser E, Arends J, Pijnenborg GHM, Wunderink L, Jörg F, Veling W, Liemburg EJ, Castelein S, Knegtering H, Bruggeman R.

Schizophr Res. 2018 Jul;197:281-287. doi: 10.1016/j.schres.2018.01.016. Epub 2018 Feb 1.

PMID:
29395613
14.
15.

Identifying levels of general distress in first line mental health services: can GP- and eHealth clients' scores be meaningfully compared?

van Bebber J, Wigman JTW, Wunderink L, Tendeiro JN, Wichers M, Broeksteeg J, Schrieken B, Sytema S, Terluin B, Meijer RR.

BMC Psychiatry. 2017 Dec 1;17(1):382. doi: 10.1186/s12888-017-1552-3.

16.

Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.

Wunderink L.

Schizophr Res. 2018 Jul;197:65-66. doi: 10.1016/j.schres.2017.11.007. Epub 2017 Nov 9. No abstract available.

PMID:
29128323
17.

Taking a Bleulerian perspective: a role for negative symptoms in the staging model?

Wunderink L.

World Psychiatry. 2017 Oct;16(3):268-270. doi: 10.1002/wps.20449. No abstract available.

18.

[Do the advantages of modern mental health care have drawbacks?]

Wunderink L.

Tijdschr Psychiatr. 2017;59(5):266-268. Dutch. No abstract available.

19.

Citalopram Discontinuation More Harmful Than Gradual Dosage Reduction?

Krijnsen PJC, van Os TWDP, Wunderink L.

Am J Psychiatry. 2017 May 1;174(5):485. doi: 10.1176/appi.ajp.2017.16101158. No abstract available.

PMID:
28457157
20.

The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.

Kraan TC, Ising HK, Fokkema M, Velthorst E, van den Berg DPG, Kerkhoven M, Veling W, Smit F, Linszen DH, Nieman DH, Wunderink L, Boonstra N, Klaassen RMC, Dragt S, Rietdijk J, de Haan L, van der Gaag M.

Psychiatry Res. 2017 Jan;247:55-62. doi: 10.1016/j.psychres.2016.11.014. Epub 2016 Nov 11.

PMID:
27863320

Supplemental Content

Loading ...
Support Center